Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival-Reference-Cited by-同舟云学术

Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival

Published:2013-09-17 Issue:9 Volume:8 Page:e74973
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Guo Chengcheng,Lu Haibo,Gao Wen,Wang Li,Lu Kaihua,Wu Shuhong,Pataer Apar,Huang Maosheng,El-Zein Randa,Lin Tongyu,Roth Jack A.,Mehran Reza,Hofstetter Wayne,Swisher Stephen G.,Wu Xifeng,Fang Bingliang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Cancer statistics, 2010;A Jemal;CA Cancer J Clin,2010

2. Reduced lung-cancer mortality with low-dose computed tomographic screening;DR Aberle;N Engl J Med,2011

3. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness;BH Goulart;J Natl Compr Canc Netw,2012

4. Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer;R Salgia;Cancer,2011

5. Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer;S Holdenrieder;Cancer Biomarkers,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer;Cell Death & Disease;2024-06-25

2. Mechanisms Underlying the Rarity of Skeletal Muscle Cancers;International Journal of Molecular Sciences;2024-06-12

3. Knock-down of IGFBP2 ameliorates lung fibrosis and inflammation in rats with severe pneumonia through STAT3 pathway;Growth Factors;2023-09-21

4. Transformer for Gene Expression Modeling (T-GEM): An Interpretable Deep Learning Model for Gene Expression-Based Phenotype Predictions;Cancers;2022-09-29

5. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer;Current Pharmaceutical Design;2022-07